Emvita 12
- Manufacturer
- RUBIMED AG
- Effective date
- 2024-10-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:29:13
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Drug Facts Active Ingredients: (HPUS*) 14.3% of each
Apis mellifica 800C Baryta carb 18LM
Eschscholtzia 21X Graphites 21X
Ignatia 16LM Naja 800C
Thymus gland 21X
*The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States. †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
INDICATIONS & USAGE SECTION
Uses: (†) Homeopathic remedy for general well being: mental overstrain.
WARNINGS SECTION
Warnings:
Stop use if symptoms persist or worsen.
If you are pregnant or breastfeeding,consult a healthcare professional prior to use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
Directions: (adults & children 6 years & older)
Take 12 drops 2 times daily, or as recommended by your health care professional.
OTHER SAFETY INFORMATION
Other information: Store at 20 - 25°C
(68 - 77°F.) Do not use if box has been
tampered with, or if the safety seal of the
bottle is broken.
INACTIVE INGREDIENT SECTION
Inactive ingredients:Ethanol 20% USP,
Purified Water.
OTC - QUESTIONS SECTION
Manufactured by: OHM pharma, Inc, USA.
Distributed by: Privia Naturals, LLC.
9169 W State St #196
Garden City, ID 83714
Info@privianaturals.com Product of USA.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 66343-099-60
RUBIMED
Emvita 12
Homeopathic Medicine For
General Well-being:
Mental Overstrain
2.0 fl oz. 59mL 20% Ethanol
OTC - PURPOSE SECTION
Homeopathic Medicine For
General Well-being:
Mental Overstain
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66343-099-60 | Emvita 12 | 60 mL in 1 BOTTLE | LIQUID | 60 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66343-099 | EMVITA 12 (APIS MELLIFICA, BARYTA CARB, ESCHSCHOLTZIA, GRAPHITES, IGNATIA, NAJA, THYMUS GLAND) LIQUID [RUBIMED AG] | 2 | Current NDC, Legacy NDC, 1 package rows | 20241201_e6b25acc-0e84-45af-9e99-cb54695d5e71.zip |
Products#
Every source-derived product name is available through these pages.
- Emvita 12
- Apis mellifica, Baryta carb, Eschscholtzia, Graphites, Ignatia, Naja, Thymus gland
- ALCOHOL
- WATER
- APIS MELLIFERA
- BARIUM CARBONATE
- BARIUM CATION
- ESCHSCHOLZIA CALIFORNICA WHOLE
- ESCHSCHOLZIA CALIFORNICA
- GRAPHITE
- STRYCHNOS IGNATII SEED
- NAJA NAJA VENOM
- BOS TAURUS THYMUS
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 66343-099 | 66343-099-60 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| APIS MELLIFERA | 7S82P3R43Z | ACTIB |
| BARIUM CARBONATE | 6P669D8HQ8 | ACTIB |
| ESCHSCHOLZIA CALIFORNICA WHOLE | 9315HN272X | ACTIB |
| GRAPHITE | 4QQN74LH4O | ACTIB |
| STRYCHNOS IGNATII SEED | 1NM3M2487K | ACTIB |
| NAJA NAJA VENOM | ZZ4AG7L7VM | ACTIB |
| BOS TAURUS THYMUS | 8XEJ88V2T8 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Emvita 12 | APIS MELLIFICA, BARYTA CARB, ESCHSCHOLTZIA, GRAPHITES, IGNATIA, NAJA, THYMUS GLAND | RUBIMED AG | e6b25acc-0e84-45af-9e99-cb54695d5e71 | 2024-10-29 | Warnings | 66343-099-60 66343-099 66343009960 28173f16-e5a9-6a34-e063-6394a90a4642 e6b25acc-0e84-45af-9e99-cb54695d5e71 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

